Moksisilit

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
Moksisilit
(IUPAC) ime
4-[2-(Dimetilamino)etoksi]-5-izopropil-2-metilfenil acetat
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 54-32-0
ATC kod G04BE06 C04AX10
PubChem[1][2] 4260
UNII PW8QYA7KI0 YesY
KEGG[3] D08239 YesY
Hemijski podaci
Formula C16H25NO3 
Mol. masa 279,375 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Moksisilit (timoksamin) je lek koji se koristi u urologiji za tretman erektilne disfunkcije. On je antagonist α1-adrenergičkog receptora.[4]

Reference[uredi - уреди | uredi kôd]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0061%28200004%2917:1%3C48::AID-YEA2%3E3.0.CO;2-H/full. 
  4. Sakakibara R, Hattori T, Uchiyama T, et al. (March 2000). „Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte”. J. Auton. Nerv. Syst. 79 (2–3): 191–5. DOI:10.1016/S0165-1838(99)00105-8. PMID 10699651. http://linkinghub.elsevier.com/retrieve/pii/S0165183899001058. 

Spoljašnje veze[uredi - уреди | uredi kôd]


Star of life.svg Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini).